Ibaraki, Japan

Mutsuko Tabata


Average Co-Inventor Count = 11.6

ph-index = 4

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Mutsuko Tabata: Pioneering Heterocyclic Compounds

Introduction: Mutsuko Tabata, a talented inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a total of four patents to her name, her research and innovations focus on developing novel compounds with potential therapeutic applications, particularly in the modulation of corticotrophin-releasing-factor receptor activities.

Latest Patents: Mutsuko's latest patents include groundbreaking work on a tricyclic fused heterocyclic compound and its preparation process. This compound boasts excellent corticotrophin-releasing-factor receptor antagonistic activity, offering promising avenues for treating various medical conditions. Another notable patent involves fused heterotricyclic compounds, also demonstrating the ability to target corticotrophin-releasing-factor receptors effectively. The innovative structures she has created allow for the development of pharmacologically acceptable salts and hydrates, which enhance the therapeutic potential of these compounds.

Career Highlights: Mutsuko Tabata currently works with Eisai Company, Limited, a leading pharmaceutical firm dedicated to innovative drug development. Her career is distinguished by her commitment to enhancing pharmaceutical efficacy through her pioneering research in heterocyclic compounds. This work not only contributes to the scientific community but also lays the groundwork for future medical advancements.

Collaborations: Throughout her career, Mutsuko has collaborated with esteemed colleagues, including Yoshinori Takahashi and Shigeki Hibi. These partnerships reflect a collaborative approach to innovation and a shared vision of advancing pharmaceutical research, ensuring that their combined expertise drives the development of effective medical solutions.

Conclusion: Mutsuko Tabata stands as a prominent figure in pharmaceutical innovation, constantly pushing the boundaries of scientific research. Her contributions in the area of heterocyclic compounds and their applications in treating complex health issues underscore the importance of her work in developing new therapeutic agents. As she continues her journey at Eisai Company, Limited, her future endeavors promise to lead to transformative advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…